Molecular diagnosis and treatment of meningiomas:an expert consensus(2022)  

作　　者：Jiaojao Deng Lingyang Hua Liuguan Bian Hong Chen Ligang Chen Hongwei Cheng Changwu Dou Dangmurenjiapu Geng Tao Hong Hongming Ji Yugang Jiang Qing Lan Gang Li Zhixiong Liu Songtao Qi Yan Qu Songsheng Shi Xiaochuan Sun Hajun Wang Yongping You Hualin Yu Shuyuan Yue Jianming Zhang Xiaohua Zhang Shuo Wang Ying Mao Ping Zhong Ye Gong Group of Neuro-Oncology Society of Neurosurgery Chinese Medical Association 

机构地区：[1]Department of Neurosurgery,Huashan Hospital,Fudan University,Shanghai 200040,China [2]National Center for Neurological Disorders,Huashan Hospital,Fudan University,Shanghai 200040,China [3]Shanghai Key Laboratory of Brain Function and Restoration and Neural Regeneration,Shanghai 200040,China [4]Neurosurgical Institute of Fudan University,Shanghai 200040,China [5]Shanghai Clinical Medical Center of Neurosurgery,Shanghai 200040,China [6]Department of Neurosurgery,Rujn Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China [7]Department of Pathology,Huashan Hospital,Fudan University,Shanghai 200040,China [8]Department of Neurosurgery,The Affiliated Hospital of Southwest Medical University,Luzhou,Sichuan 646000,China [9]Department of Neurosurgery,The First Affiliated Hospital of Anhui Medical University,Hefei,Anhui 230022,China [10]Department of Neurosurgery,The Affiliated Hospital of Inner Mongolia Medical Universty,Hoho,Inner Mongolia 750306,China [11]Department of Neurosurgery,The First Affiliated Hospital of Xinjiang Medical University,Urumqi,Xinjang 830011,China [12]Department of Neurosurgery,The First Affiliated Hospital of Nanchang University,Nanchang,Jiangxi 330006,China [13]Department of Neurosurgery,Shanxi Medical Universty Shanxi Provincial People's Hospita,Taiyuan,Shanxi 030012,China [14]Department of Neurosurgery,The Second Xiangya Hospital,Central South University,Changsha,Hunan 410011,China [15]Department of Neurosurgery,The Second Affiliated Hospital of Soochow University,Soochow,Jjangsu 215004,China [16]Deparment of Neurosurgery,Qiu Hospital,Cheeloo College of Medicine and Insttute of Brain and Brain-Inspired Science,Shandong University Jinan,Shandong 25003,China [17]Department of Neurosurger,Xiangya Hospital,Central South Uuniversit,Changsha,Hunan 410008,China [18]Department of Neurosurgery,Nanfang Hospital,Southern Medical Universty,Guangzhou,Guangdong 510515,China [19]Department of Neurosurgery,Tangdu Hospital,The Fourth Miltay Medial Universt,Xi'an,Shaanxi 710038,China

出　　处：《Chinese Medical Journal》2022年第16期1894-1912,共19页中华医学杂志（英文版）

摘　　要：Meningiomas are the most common primary intracranial neoplasm with diverse pathological types and complicated clinical manifestations.The fifth edition of the WHO Classification of Tumors of the Central Nervous System(WHO CNS5),published in 2021,introduces major changes that advance the role of molecular diagnostics in meningiomas.To follow the revision of WHO CNS5,this expert consensus statement was formed jointly by the Group of Neuro-Oncology,Society of Neurosurgery,Chinese Medical Association together with neuropathologists and evidence-based experts.The consensus provides reference points to integrate key biomarkers into stratification and clinical decision making for meningioma patients.

关 键 词：Clinical diagnosis Expert consensus MENINGIOMA Molecular subtyping Therapeutic treatment 

分 类 号：R739.45[医药卫生—肿瘤]